For over five decades, federal regulators have only authorized a single licensee – the University of Mississippi – to cultivate cannabis plants for use in FDA-approved clinical studies.
“These common-sense regulatory changes are necessary and long overdue. The reality that most high-schoolers have easier access to cannabis than do our nation’s top scientists is the height of absurdity and an indictment of the current system.”
“Current or ever use of cannabis for menopause symptom management was reported by 27 percent of all participants, while an additional 10 percent expressed interest in future use.”
“Just as the majority of those who consume alcohol prefer relatively low potency beer or wine over hard liquor, most adult-use cannabis consumers gravitate toward herbal cannabis preparations and away from the comparatively stronger alternatives.”
“Over the course of our study, … we identified a significant and progressive increase in the number of patients using cannabis. In patients with chronic pain, cannabis use more than doubled during this period.”
“Our finding that occasional marijuana was not associated with ECG abnormalities adds to the growing body of evidence that this level of marijuana use and CVD events and markers of subclinical atherosclerosis are not associated.”
“Taken together, the results of this study add to the cumulative evidence in support of plant-based MC (medical cannabis) as a safe and effective treatment option and potential opioid substitute or augmentation therapy for the management of chronic pain symptomatology and quality of life.”